CLINICAL_TRIALS
trial_result
· 2017-10-16
Clinical Trial Update: A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) [Phase 2]
Summary
A Phase 2 study evaluating two doses of GSK2402968 in Duchenne muscular dystrophy has completed, with results posted in October 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Muscular Dystrophies | Phase 2 | Status: COMPLETED | Results posted: 2017-10-16